Health & Science

Home Health & Science

Justice Department Opens Investigation Into Former Gov. Andrew Cuomo

Photos from the opening of the new Delta Air Lines terminal in LaGuardia Airport in Queens, NY, on Tuesday, Oct. 29, 2019. (Chris Rank for Rank Studios) (Photos from the opening of the new Delta Air Lines terminal in LaGuardia Airport in Queens, NY, o

The U.S. Department of Justice has opened a criminal investigation into former New York Gov. Andrew Cuomo for allegedly lying to Congress about his decisions made during the COVID-19 pandemic while serving as governor, a source familiar with the probe confirmed to Fox News.

The New York Times first reported that the U.S. attorney’s office in Washington opened the inquiry into Cuomo about a month ago after senior officials in the DOJ demanded an indictment of New York City Mayor Eric Adams for corruption charges be dismissed.

Cuomo is running in the Democratic primary to serve as the next mayor of New York City, while Adams is seeking re-election as an independent candidate.

“We have never been informed of any such matter, so why would someone leak it now? The answer is obvious: This is lawfare and election interference plain and simple—something President Trump and his top Department of Justice officials say they are against,” Rich Azzopardi, Cuomo’s spokesperson told Fox News. “Governor Cuomo testified truthfully to the best of his recollection about events from four years earlier, and he offered to address any follow-up questions from the Subcommittee — but from the beginning this was all transparently political.”

Last year, Republican lawmakers questioned Cuomo about his handling of the COVID-19 pandemic. House Republicans subsequently recommended the Justice Department pursue criminal charges against him. They accused him of intentionally lying to Congress during the House Oversight Committee’s investigation into the excessive number of nursing home deaths.

House Oversight and Government Reform Committee Chair James Comer (R-Ky.) referred Cuomo to President Donald Trump’s Justice Department for criminal prosecution. 

Cuomo, who was governor at the time, issued a March 2020 directive that initially barred nursing homes from refusing to accept patients who had tested positive for COVID-19. The directive was aimed at freeing up beds for overwhelmed hospitals. 

More than 9,000 recovering coronavirus patients were released from hospitals into nursing homes under the directive, which was later rescinded amid speculation that it had accelerated outbreaks. Cuomo has previously said that the directive was based on the Centers for Disease Control and Prevention (CDC) and Centers for Medicare and Medicaid Services (CMS) guidance at the time.

A report released in March 2022 by the New York state comptroller found Cuomo’s Health Department “was not transparent in its reporting of COVID-19 deaths in nursing homes” and it “understated the number of deaths at nursing homes by as much as 50%” during some points of the pandemic. 

In a letter to Attorney General Pam Bondi last month, Comer said, “to our knowledge, the Biden Administration ignored this referral despite clear facts and evidence.” He requested that Bondi review the referral and “take appropriate action.” 

“Andrew Cuomo is a man with a history of corruption and deceit, now caught red-handed lying to Congress during the Select Subcommittee’s investigation into the COVID-19 nursing home tragedy in New York,” Comer said in a statement Monday. “This wasn’t a slip-up – it was a calculated cover-up by a man seeking to shield himself from responsibility for the devastating loss of life in New York’s nursing homes. Let’s be clear: lying to Congress is a federal crime. Mr. Cuomo must be prosecuted to the fullest extent of the law. The House Oversight Committee is prepared to fully cooperate with the Justice Department’s investigation into Andrew Cuomo’s actions and ensure he’s held to account.” 

Report: White House Chief Of Staff Diagnosed With Cancer

0

On Monday, President Trump revealed White House Chief of Staff Susie Wiles has been diagnosed with early stage breast cancer.

“She has a fantastic medical team and her prognosis is excellent,” Trump said in a Truth Social post.

Trump went on to call Wiles “one of my closest and most important advisors.” 

“Melania and I are with her in every way, and we look forward to working with Susie on the many big and wonderful things that are happening for the benefit of our Country!” the president said.

This is a breaking news story. Please check back for updates.

Noem Hospitalized After Allergic Reaction; Biohazard Lab Visit Under Scrutiny

1
Photo via Pixabay images

On the evening of Tuesday, June 17, 2025, Homeland Security Secretary Kristi Noem was rushed by ambulance to a Washington, D.C. hospital after suffering what officials described as an allergic reaction. According to a statement from the Department of Homeland Security (DHS), Noem was treated “out of an abundance of caution” and remains in stable condition.

The medical emergency drew swift attention — not only because of Noem’s high-profile cabinet role, but also due to the timing. Just one day earlier, she had visited the Integrated Research Facility at Fort Detrick, Maryland, a high-security federal lab that handles some of the world’s most dangerous pathogens, including Ebola and SARS-CoV-2. She was accompanied on the tour by Health and Human Services Secretary Robert F. Kennedy Jr. and Senator Rand Paul (R-Ky.).

The Fort Detrick facility has been under scrutiny in recent months. In April, it was temporarily shut down following safety concerns involving possible tampering with personal protective equipment. Though the lab has since resumed operations, the incident left lingering questions about oversight and internal protocols.

While the proximity of Noem’s hospital visit to her tour of the lab has sparked speculation, DHS downplayed any connection. Officials stressed there is no indication the allergic reaction had anything to do with the biohazard site, and current evidence points to coincidence, not causation.

Still, the lack of detail surrounding Noem’s condition — and the decision to visit to a facility recently flagged for a safety lapse — has fueled speculation. Noem has not issued a public statement since the incident, though an official told the Associated Press that the secretary is “alert and recovering.”

Security around the hospital was visibly heightened following Noem’s arrival, with multiple eyewitnesses reporting Secret Service personnel stationed at emergency entrances and perimeter points.

As of now, Noem remains under medical supervision, and DHS has indicated she will resume duties once cleared by her doctors. The department has not disclosed whether additional tests are being conducted to rule out environmental or chemical triggers.

What We Know — and Don’t

The facts are straightforward, even if the full picture isn’t: Secretary Noem had an acute medical event. She had just visited a facility known for housing lethal biological agents. There’s no official link between the two events. But in an era when institutional trust runs thin and information gaps invite conspiracy theories, the sequence of events is likely to keep this story alive longer than a typical health scare.

For now, DHS says Noem is recovering and expected to make a full recovery. But until more details emerge — from medical professionals or Noem herself — the story will likely remain a focus of intense public interest.

READ NEXT: Musk Confronts Key Ally — Forces Bombshell Admission

Karoline Leavitt Prepares For Second Child As White House Weighs Temporary Shift

Gage Skidmore from Surprise, AZ, United States of America, CC BY-SA 2.0 , via Wikimedia Commons


White House press secretary Karoline Leavitt is expected to welcome her second child this week, adding a personal milestone to a tenure already defined by firsts. At 28, she is the youngest press secretary in U.S. history and the first known to serve in the role while pregnant.

Her upcoming leave raises practical questions for the administration, including how long she plans to step away and how the White House will manage one of its most visible daily responsibilities in her absence.

Unclear timeline for leave

A White House official said it’s not yet clear how much time Leavitt will take off after the birth. Like other federal employees, she is generally entitled to up to 12 weeks of paid parental leave. Whether she uses the full period remains an open question.

That uncertainty leaves the briefing schedule in a flexible position, with no firm timeline for her return to the podium.

No interim press secretary planned

Instead of naming a temporary replacement, the White House plans to rely on a rotating group of officials to handle press briefings. That group could include President Donald Trump and Vice President JD Vance, an approach that would break from the more traditional model of a single, consistent spokesperson.

The decision signals a willingness to experiment, but it also introduces the possibility of mixed messaging. Different officials bring different styles, and consistency has long been a priority in managing daily communication with the press.

Family life in the public eye

Leavitt first announced her pregnancy in December, sharing that she and her husband, Nicholas Riccio, were expecting a daughter. Their first child, Niko, was born in July 2024 and has already appeared in the briefing room during special events.

In a social media post after Christmas, Leavitt said she was looking forward to becoming a “girl mom” and described the coming year as meaningful for her family. She also pointed to what she called a supportive, pro-family culture within the White House, crediting both President Trump and chief of staff Susie Wiles.

Staying active on the job

Leavitt continued her duties throughout the pregnancy, rarely stepping back from the demands of the role. That includes leading daily briefings and serving as a central voice for the administration during a busy stretch of domestic and international developments.

Her tenure has also brought changes to the structure of the briefing room. Most notably, she introduced a designated space for “new media,” giving podcasters, independent journalists, and digital creators a more visible presence.

She has often called on those voices early in briefings, a shift away from the traditional dominance of legacy outlets.

A test for a changing briefing room

Leavitt’s temporary absence could put that evolving setup to the test. With multiple officials rotating through the podium, the tone and priorities of briefings may shift from day to day.

That variability may not matter much during quieter periods. But in moments that require clear, unified messaging, it could become more noticeable.

Balancing public service and private life

For now, the focus remains on a personal milestone. Even in a role tied closely to national politics and constant scrutiny, family life continues alongside the job.

Leavitt’s situation underscores a familiar challenge in Washington: balancing the demands of public service with life outside the office. It’s not unique, but it’s rarely this visible.

Her return, whenever it comes, will likely bring the operation back to a more familiar rhythm. Until then, the White House is preparing to adjust on the fly.

READ NEXT: Major City Removes Leader Following Appalling Lawsuit

Republican Congressman Hospitalized In Car Accident

Photo via Pixabay images

Rep. Jim Baird (R-Ind.) has reportedly been hospitalized after a car accident.

Baird is responsive and in stable condition, Fox News reported.

Baird’s hospitalization came moments after it was announced House GOP Rep. Doug LaMalfa (R-Calif.) had suddenly passed away at age 65.

LaMalfa represented part of California and was chair of the Congressional Western Caucus.

“Jacquie and I are devastated about the sudden loss of our friend, Congressman Doug LaMalfa. Doug was a loving father and husband, and staunch advocate for his constituents and rural America. Our prayers are with Doug’s wife, Jill, and their children,” Emmer said.

His death brings House Republicans’ majority down to 218 to 213. 

Trump Aide Faints On Stage During Republican Gala

1
Photo via Pixabay images

An adviser to President-elect Trump’s campaign, Alex Bruesewitz, passed out and collapsed as he was speaking onstage during a New York Young Republican Club gala Sunday night.

Alex Bruesewitz, 27, was introducing incoming White House senior aide Dan Scavino inside a venue in Manhattan when he began stumbling over his words and fainted, video on social media shows.

Watch:

Several people quickly rushed to help after his collapse. It was not immediately clear what caused him to faint.

“I talked to our friend Alex Bruesewitz and you know what he said to me? He goes ‘Did I at least look cool?’ I said Alex, you used gravity like I’ve seen nobody use gravity before in their lives,” Kassam said. “But he’s recuperating back there, so give him a big cheer so he’ll hear you.”

Trump also said following the collapse that he believes Bruesewitz will be fine, according to the New York Post.

“I know that Alex is going to be fine because he’s a tough son of a gun,” Trump said. “There’s no doubt about that. So I want to say hello to Alex, because he’s a very special guy.”

Bruesewitz is the CEO of consultancy firm X Strategies LLC, which states its mission to help elect “America First” candidates. Its website says he is “a prominent political consultant and strategist known for his unwavering support of President Donald Trump and the America First agenda.”

Before his collapse, Bruesewitz commended the New York Republican Club for backing Trump’s campaign. He also gave shout-outs to several supporters of the incoming president who were at the event, including former Florida congressman Matt Gaetz, who recently resigned from his U.S. House seat.

Trump Signs Executive Order To Tie US Drug Prices To Global Lows

0

On Monday morning, President Donald Trump signed a sweeping executive order aimed at dramatically lowering prescription drug prices in the United States. At the center of the order is a “most favored nation” (MFN) pricing policy, which mandates that the U.S. pay no more for medications than the lowest price paid by any other country. Trump claims the initiative could cut drug prices by 30% to 80%, potentially saving American taxpayers trillions of dollars.

The MFN policy revives a proposal from Trump’s first term and targets the longstanding disparity in drug costs between the U.S. and other nations. The order also directs the Department of Health and Human Services to begin broad drug price negotiations, while introducing measures to combat anti-competitive practices, expand drug imports, and scrutinize the role of pharmacy benefit managers (PBMs).

The New York Post reports:

“What’s been happening is, we’ve been subsidizing other countries throughout the world,” Trump explained at a White House signing ceremony, calling Monday’s action one of his “most important orders.”

“Some prescription drug and pharmaceutical prices will be reduced almost immediately by 50 to 80 to 90%, he added. “Big Pharma will either abide by this principle voluntarily or we’ll use the power of the federal government to ensure that we are paying the same price.”

The policy is a revival of Trump’s signature “most favored nation” drive from his first term, with a new push to get foreign countries to take on more of the research and development (R&D) costs that experts say America has disproportionately shouldered.

“Our Country will finally be treated fairly, and our citizens Healthcare Costs will be reduced by numbers never even thought of before,” the president previously promised on Truth Social Sunday. “The United States will save TRILLIONS OF DOLLARS.”

The announcement triggered immediate market reaction, with shares of pharmaceutical giants like AstraZeneca and GSK seeing declines. Industry leaders have warned the policy could stifle innovation and competition, arguing it may disincentivize research and development.

Although the Biden administration previously took steps to lower drug prices through the Inflation Reduction Act, Trump’s executive order takes a more aggressive approach by linking U.S. prices directly to global lows.

However, the new policy is expected to face significant legal and logistical hurdles, particularly due to the complexity of the U.S. drug pricing system and the opaque nature of international pricing mechanisms.

Supreme Court Greenlights Trump NIH Cuts Targeting DEI, COVID Research

The U.S. Supreme Court on Thursday cleared the way for the Trump administration to move forward with nearly $800 million in cuts to National Institutes of Health grants.

The decision allows the administration to withhold funds that had been frozen by a lower court — grants largely tied to diversity, equity, and inclusion (DEI) initiatives, as well as studies focused on minority health, LGBTQ+ issues, vaccine hesitancy, COVID-19, and similar public health topics.

A federal trial court in Massachusetts had previously ruled in June that many of the cuts were “arbitrary and discriminatory,” ordering the temporary restoration of those grants.

But the Supreme Court, acting through its emergency — or so-called “shadow” — docket, overrode that ruling in a narrow 5–4 decision.

Chief Justice John Roberts sided with the liberal bloc in dissent. Justice Ketanji Brown Jackson issued a sharply worded dissent of her own, criticizing the court’s reliance on the emergency process and the brevity of the majority’s explanation.

As SCOTUSBlog reports, the court — also by a 5–4 margin — left in place another part of the lower court’s ruling affecting internal NIH guidance documents outlining the agency’s policy priorities:

Justice Amy Coney Barrett provided the key vote on each issue. She joined Justices Clarence Thomas, Samuel Alito, Neil Gorsuch, and Brett Kavanaugh in voting to allow NIH to terminate the grants, but she joined Chief Justice John Roberts and Justices Sonia Sotomayor, Elena Kagan, and Ketanji Brown Jackson in voting to leave the lower court’s ruling on the guidance documents in place.

Jackson had sharp words for her colleagues, describing the ruling as “Calvinball jurisprudence” – a reference to the Calvin and Hobbes cartoon – “with a twist. Calvinball has only one rule: There are no fixed rules. We seem to have two: that one, and this Administration always wins.”

NIH ended hundreds of grants it linked to DEI-related studies in response to a series of executive orders issued by President Donald Trump after his inauguration in January. The first order, titled “Ending Radical and Wasteful Government DEI Programs and Preferencing,” instructed the director of the Office of Management and Budget, assisted by the attorney general and the director of the Office of Personnel Management, to work to end “discriminatory programs, including illegal DEI” programs in the federal government. It was followed by two other executive orders, titled “Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government” and “Ending Illegal Discrimination and Restoring Merit-Based Opportunity.”

Two separate groups of plaintiffs went to federal court in Massachusetts to challenge the termination of the grants. One group is made up of 16 states whose public universities receive funding from NIH, while the other consists of the American Public Health Association, individual researchers, a union, and a reproductive health advocacy group. They contended that the termination of the grants violated both the Constitution and the Administrative Procedure Act, the federal law governing administrative agencies.

The administration argues the research in question lacks scientific rigor and was driven more by ideology than merit. Officials also say the cuts are consistent with their broader push to eliminate DEI-related spending across federal agencies.

Democrat-led states and advocacy groups claim the funding loss could have “incalculable” consequences for underserved communities.

This case fits a broader pattern: The court has recently upheld rollbacks on DEI-based spending in areas like teacher training. Critics say the use of the emergency docket limits public transparency and bypasses full hearings. Supporters say it’s a legitimate tool to keep activist courts in check.

Legal challenges are still moving through the lower courts.

In the meantime, universities, NIH personnel, and left-leaning advocacy groups are mobilizing in protest, warning of long-term damage to public health research and institutional equity efforts.

READ NEXT: Police Swarm Former Trump Ally’s Mansion

Trump Breaks Silence On Biden’s Cancer Diagnosis

0
The White House, Public domain, via Wikimedia Commons

President Donald Trump expressed sympathy for former President Joe Biden following Sunday’s surprise announcement of Biden’s aggressive prostate cancer diagnosis. In a Truth Social post, Trump stated:

“Melania and I are saddened to hear about Joe Biden’s recent medical diagnosis. We extend our warmest and best wishes to Jill and the family, and we wish Joe a fast and successful recovery.”

Biden, 82, was diagnosed with a high-grade, hormone-sensitive prostate cancer that has metastasized to the bone. Biden and his family are currently reviewing treatment plans with his medical team.

Trump’s message marks a notable moment of bipartisan compassion amid ongoing political tensions.

In his first public statement following the diagnosis, Biden expressed gratitude for the outpouring of support, saying:

“Cancer touches us all. Like so many of you, Jill and I have learned that we are the strongest in broken places.”

The announcement has prompted a wave of bipartisan support, with messages of encouragement from various political figures, including Kamala Harris and Barack Obama.

However, not all reactions have been as supportive. Donald Trump Jr. initially shared a message wishing President Biden a speedy recovery but later posted a controversial comment questioning how Dr. Jill Biden could have missed signs of advanced cancer, suggesting a possible cover-up. “What I want to know is how did Dr. Jill Biden miss stage five metastatic cancer—or is this yet another cover-up???” Trump Jr. wrote on X (formerly Twitter). His post was widely criticized for its accusatory tone and for failing to note that Jill Biden holds a doctorate in education, not medicine.

According to Newsweek‘s reporting, the cancer presumably developed rapidly, despite Biden’s routine screenings intended to detect it early:

A professor of oncology told Newsweek that Joe Biden would have been tested for prostate cancer while in office and it is likely his cancer developed rapidly.

Gage Skidmore, CC BY-SA 2.0 , via Wikimedia Commons

Biden’s age and health were dominant concerns among voters during his time as president. The 82-year-old dismissed concerns about his mental acuity, but ultimately dropped his bid for a second term following a disastrous debate performance in June last year. He was replaced as the Democratic nominee by then-Vice President Kamala Harris, who lost to President Donald Trump.

Questions have been raised about the Biden administration and campaign’s transparency about Biden’s age and cognitive ability. An upcoming book alleges White House aides covered up Biden’s physical and mental decline. However, there is no current indication publicly available that Biden was diagnosed with prostate cancer during his tenure as president.

Biden’s office said the former president was diagnosed with prostate cancer on Friday, with the cancer cells having spread to the bone.

Tulsi Gabbard Provides Update On Husband’s Condition

Outgoing Director of National Intelligence Tulsi Gabbard shared an encouraging update Thursday on her husband’s battle with a rare form of bone cancer, revealing that a major surgery to remove the tumor was successful.

Gabbard said her husband, Abraham Williams, recently underwent a nearly seven-hour operation after being diagnosed with sacral chordoma, an extremely rare cancer that forms in the bones of the spine and skull base.

“The surgery to remove bone and surrounding tissue lasted almost seven hours and was successful,” Gabbard wrote in a post on X.

“He had a rough night and is in a lot of pain, but is finally home resting.”

The Trump administration official said the family is now focused on the recovery process.

“Now recovery begins. We’re so grateful for the outpouring of prayers and kind messages from all of you. Our hearts are full,” Gabbard added.

According to Mayo Clinic research, sacral chordoma is a rare, slow-growing bone cancer that most commonly develops along the spine. While considered slow-growing, the disease can be difficult to treat because of its location, and surgery is often the primary treatment option.

Before the procedure, Gabbard shared a heartfelt message thanking supporters for their prayers.

“We are humbled and so grateful to be surrounded by aloha during this really tough time,” she wrote.

The update comes just weeks after Gabbard announced she would step down from her position in the Trump administration to support her husband through the difficult battle ahead. (RELATED: Tulsi Gabbard Resigning As National Intelligence Director)

“My husband, Abraham, has recently been diagnosed with an extremely rare form of bone cancer,” Gabbard wrote in May. “He faces major challenges in the coming weeks and months. At this time, I must step away from public service to be by his side and fully support him through this battle.”

President Donald Trump praised Gabbard following her resignation announcement, saying she had done “an incredible job” serving in his administration.

Vice President JD Vance also voiced support for the former Hawaii congresswoman.

“I’m sorry to see her go, but certainly understand that family comes first,” Vance said. “She and her husband Abraham will be in my prayers as they face this next challenge together, and she has my gratitude for being a great addition to the administration and a loyal confidante. Godspeed Tulsi!”

Gabbard’s final day in office is expected to be June 30.

The White House has also tapped Federal Housing Finance Agency Director William J. “Bill” Pulte to assume Gabbard’s intelligence role following her departure.

Gabbard, a former Democrat congresswoman from Hawaii, became one of the most prominent political converts of the 2024 election cycle when she endorsed Trump’s presidential campaign and later joined his administration.